Abstract
Background Mental illness was identified associated with high risk of cardiovascular diseases (CVDs). However, few studies focused on the effect of personality traits, the causal relationships remain unknown. Here, we use mendelian randomization (MR) analyses to evaluate the causal association between mood instability (mood swings) and 5 common CVDs.
Methods Large genome-wide association studies (GWAS) of mood swings (n= 373733) and 5 CVDs from two independent cohorts respectively including coronary artery disease (CAD) (n= 766053), myocardial infarction (MI) (n= 596436), heart failure (HF) (n= 1185501), atrial fibrillation (AF) (n= 2169833) and stroke (n = 627558). We performed a range of bidirectional two-sample MR and related sensitive analysis including MR-Egger regression, MR-PRESSO global test and “Leave-one-out” method. A Bonferroni-corrected significance level of p < 0.01 (0.05/5) was identified to be statistically significant, while p < 0.05 was considered to indicate suggestive evidence. Moreover, multivariable MR (MVMR) and mediation analyses were also conducted to adjust confounding factors as well as found potential mediators.
Results This MR analyses revealed the significant causal effects of mood swings on CAD (OR = 1.45, 95% CI 1.24–1.71; P = 5.52e-6), MI (OR = 1.60, 95% CI 1.32–1.95; P = 1.77e-6), HF (OR = 1.42, 95% CI 1.12–1.71; P = 2.32e-6) and stroke (OR = 1.48, 95% CI 1.19–1.83; P = 3.46e-4). However, no causal effects of mood swings on AF (P=0.16) were found. In the reverse MR, no causal relationships were observed. Additionally, hypertension may mediate the causal pathway from mood swings to CAD (proportion of mediation effect in total effect: 39.60%, 95% CI: 19.31%–59.89%), MI (35.37%, 95% CI: 17.10%–53.65%), HF (43.19%, 95% CI: 20.68%–65.69%) and stroke (55.47%, 95% CI: 27.00%–83.95%).
Conclusion Mood instability (mood swings) causally resulted in CAD, MI, HF and stroke, and these causal effects may be partly mediated by hypertension.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the Suzhou Science and Technology Project (SKYD2022103), Suzhou Specialized Program for Diagnosis and Treatment Techniques of Clinical Key Diseases (LCZX202103), and Soochow University (P112206422).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All the summary statistics were publicly available which obtained from the Open GWAS database developed by the MRC Integrative Epidemiology Unit (IEU) (https://gwasmrcieu.ac.uk/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at https://gwasmrcieu.ac.uk/
